DK314487A - Benzoxepinderivat - Google Patents

Benzoxepinderivat

Info

Publication number
DK314487A
DK314487A DK314487A DK314487A DK314487A DK 314487 A DK314487 A DK 314487A DK 314487 A DK314487 A DK 314487A DK 314487 A DK314487 A DK 314487A DK 314487 A DK314487 A DK 314487A
Authority
DK
Denmark
Prior art keywords
derivatives
activity
benzoxepin
phenylbenzoxepin
plateles
Prior art date
Application number
DK314487A
Other languages
English (en)
Other versions
DK166676B1 (da
DK314487D0 (da
Inventor
Toshio Tatsuoka
Kayoko Nomura
Fumio Satoh
Takafumi Ishihara
Seiji Miyano
Kunihiro Sumoto
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Publication of DK314487D0 publication Critical patent/DK314487D0/da
Publication of DK314487A publication Critical patent/DK314487A/da
Application granted granted Critical
Publication of DK166676B1 publication Critical patent/DK166676B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
DK314487A 1986-06-20 1987-06-19 2-phenoxybenzoxepinderivater, farmaceutisk praeparat indeholdende et saadant derivat, samt en fremgangsmaade til fremstilling af derivaterne DK166676B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14289886 1986-06-20
JP14289886 1986-06-20

Publications (3)

Publication Number Publication Date
DK314487D0 DK314487D0 (da) 1987-06-19
DK314487A true DK314487A (da) 1987-12-21
DK166676B1 DK166676B1 (da) 1993-06-28

Family

ID=15326163

Family Applications (1)

Application Number Title Priority Date Filing Date
DK314487A DK166676B1 (da) 1986-06-20 1987-06-19 2-phenoxybenzoxepinderivater, farmaceutisk praeparat indeholdende et saadant derivat, samt en fremgangsmaade til fremstilling af derivaterne

Country Status (10)

Country Link
US (1) US4845094A (da)
EP (1) EP0250265B1 (da)
JP (1) JPH0813807B2 (da)
AT (1) ATE56211T1 (da)
AU (1) AU597671B2 (da)
CA (1) CA1277320C (da)
DE (1) DE3764724D1 (da)
DK (1) DK166676B1 (da)
ES (1) ES2017498B3 (da)
HU (1) HU206108B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4997836A (en) * 1988-11-11 1991-03-05 Takeda Chemical Industries, Ltd. Trisubstituted piperazine compounds, their production and use
JP2851054B2 (ja) * 1989-03-15 1999-01-27 サントリー株式会社 ベンズオキセピン誘導体
FR2698873B1 (fr) * 1992-12-07 1995-02-24 Lipha Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant.
ES2316664T3 (es) * 1994-08-05 2009-04-16 BAUSCH & LOMB INCORPORATED Un metodo para envasas una lente intraocular.
US6262277B1 (en) 1994-09-13 2001-07-17 G.D. Searle And Company Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US6268392B1 (en) 1994-09-13 2001-07-31 G. D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US6221897B1 (en) 1998-06-10 2001-04-24 Aventis Pharma Deutschland Gmbh Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
DK1140189T3 (da) 1998-12-23 2003-09-15 Searle Llc Kombinationer af ileal galdesyre-transportinhibitorer og fibrinsyrederivater til cardiovaskulære indikationer
AU2157500A (en) 1998-12-23 2000-07-31 G.D. Searle Llc Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
BR9916486A (pt) 1998-12-23 2002-02-05 Searle Llc Combinações de inibidores do transporte de ácidos biliares no ìleo e inibidores da proteìna de transferência do ester colesteril para indicações cardiovasculares
EA004877B1 (ru) 1998-12-23 2004-08-26 Джи.Ди.Сирл Ллс Сочетания ингибиторов транспорта желчных кислот в подвздошной кишке и агентов, секвестрирующих желчные кислоты, для сердечно-сосудистых показаний
AU3103800A (en) 1998-12-23 2000-07-31 G.D. Searle Llc Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acidderivatives for cardiovascular indications
US6458850B1 (en) 1998-12-23 2002-10-01 G.D. Searle, Llc Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
AU2157400A (en) 1998-12-23 2000-07-31 G.D. Searle & Co. Combinations of cholesteryl ester transfer protein inhibitors and hmg coa reductase inhibitors for cardiovascular indications
EP1286984A2 (en) 2000-03-10 2003-03-05 Pharmacia Corporation Method for the preparation of tetrahydrobenzothiepines
BR0213501A (pt) 2001-11-02 2004-08-24 Searle Llc Compostos de benzotiepina mono- e di-fluorada como inibidores de transporte de ácido biliar co-dependente de sódio apical (asbt) e captação de taurocolato
MXPA04006255A (es) 2002-01-17 2004-09-27 Pharmacia Corp Compuestos novedosos de alquil/aril hidroxi o ceto tiepina como inhibidores del transporte del acido biliar codependiente del sodio apical y la captacion de taurocolato.
JP6217938B2 (ja) 2011-10-28 2017-10-25 ルメナ ファーマシューティカルズ エルエルシー 小児の胆汁うっ滞性肝疾患の処置のための胆汁酸再循環阻害剤
EA038594B1 (ru) 2011-10-28 2021-09-21 Шайр Хьюман Дженетик Терапис, Инк. Ингибиторы рециркуляции желчных кислот для лечения гиперхолемии и холестатического заболевания печени
WO2016019587A1 (en) * 2014-08-08 2016-02-11 Merck Sharp & Dohme Corp. [7, 6]-fused bicyclic antidiabetic compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1593760A1 (de) * 1967-02-01 1972-06-08 Boehringer Sohn Ingelheim Verfahren zur Herstellung neuer Benz-epinderivate
DE2931399A1 (de) * 1979-08-02 1981-02-26 Kali Chemie Pharma Gmbh Neue 3-amino-1-benzoxepin-derivate und ihre salze, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3440295A1 (de) * 1984-11-05 1986-05-15 Kali-Chemie Pharma Gmbh, 3000 Hannover Verfahren zur diastereoselektiven reduktion von 3-amino-1-benzoxepin-5(2h)-onen
US4736031A (en) * 1985-06-10 1988-04-05 Takeda Chemical Industries, Ltd. 2-(piperazinylalkyl)-1-benzothiepin, 1-benzoxepin, and 1,5-benzodioxepin derivatives

Also Published As

Publication number Publication date
DK166676B1 (da) 1993-06-28
ATE56211T1 (de) 1990-09-15
ES2017498B3 (es) 1991-02-16
DK314487D0 (da) 1987-06-19
US4845094A (en) 1989-07-04
EP0250265B1 (en) 1990-09-05
JPH0813807B2 (ja) 1996-02-14
HU206108B (en) 1992-08-28
AU7424587A (en) 1987-12-24
DE3764724D1 (de) 1990-10-11
HUT48231A (en) 1989-05-29
JPS63107972A (ja) 1988-05-12
AU597671B2 (en) 1990-06-07
CA1277320C (en) 1990-12-04
EP0250265A1 (en) 1987-12-23

Similar Documents

Publication Publication Date Title
DK314487D0 (da) Benzoxepinderivat
HUT43582A (en) Process for production of derivatives of 4,5,6-substituated-n-/substituated phenil/-piramidin-amin and medical compounds containing thereof
DE3872495D1 (de) Herstellung von 3,3,3-trifluoropropen.
AU577928B2 (en) Labd-14-en-11-one derivatives
NO179518C (no) AnalogifremgangsmÕte for fremstilling av 2- hydroksymetylcytosin-substituerte 1,3-oksatiolaner
FI921087A0 (fi) Nya estrar av tienylkarboxylsyror och aminoalkoholer, deras kvaterniseringsprodukter och framstaellning och anvaendning av naemnda foereningar.
NO870890L (no) FremgangsmŸte for fremstilling av aromatiske 2-aminoalkyl-1,2-benzoisothiazol-3-(2h)-on-1,1-dioxyd-derivater.
YU69289A (en) Substituted flavonoidic compounds, their salts and process for producing thereof
DE3785740D1 (de) Verwendung von carboxamid-verbindungen zur herstellung eines arzneimittels zur behandlung der hyperlipaemie.
ES525786A0 (es) Un procedimiento para preparar derivados de pirazolo (3,4-b) piridina
NO168654C (no) Fremgangsmaate for polymerisering av 1,3-butadien.
NO871939L (no) Fremgangsmaate for oeket ekspresjon av interleukin-2.
FI896075A7 (fi) Menetelmä 4,5,6,7-tetrahydrobentsimidatsolijohdosten valmistamiseksi
DE3870723D1 (de) Herstellung von ascorbinsaeure-6-estern.
DE68909125D1 (de) Selektive Herstellung von 2,6-Diäthylnaphthalin.
NO167807C (no) Analogifremgangsmaate til fremstilling av 3',4'-dinitrogensubstituerte epipodofyllotoksinglukosidderivater.
DE3786562D1 (de) 2,6-dideoxy-2-fluoro-l-talopyranose, derivate davon und herstellung dieser verbindungen.
FI883759A0 (fi) C.12-modifierade etromycin a-derivat.
FI93454B (fi) Menetelmä terapeuttisesti aktiivisten tiasykloalkeno/3,2-b/pyridiinien valmistamiseksi
NO885200D0 (no) FremgangsmŸte for fremstilling av pro-legemidler.
DE68907733D1 (de) Herstellung von duesen.
FI891111A0 (fi) Menetelmä 1,4-dihydropyridiinijohdannaisten valmistamiseksi
PH23992A (en) Optically active 2,3-dihydrobenzoxazine derivatives and process for preparing the same
GR3003638T3 (da)
DE3787499D1 (de) Herstellung eines Plasminogenaktivators.